Brennan Kevin M. 4
4 · Xilio Therapeutics, Inc. · Filed Aug 18, 2023
Insider Transaction Report
Form 4
Brennan Kevin M.
SVP, FINANCE AND ACCOUNTING
Transactions
- Award
Stock Option (right to buy)
2023-08-16+25,000→ 25,000 totalExercise: $2.79Exp: 2033-08-15→ Common Stock (25,000 underlying)
Footnotes (1)
- [F1]The option award was granted on August 16, 2023 and shall vest with respect to 1/3 of the shares of common stock underlying the stock option on the first anniversary of the grant date and with respect to the remaining 2/3 of the shares of common stock underlying the stock option on the second anniversary of the grant date.